Margaret Gatti-Mays

17PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental communicationPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 25, 2026
Too much, too soon?-trastuzumab deruxtecan in the first line metastatic setting.

|Mar 02, 2026
Can I Have One Minute of Your Time? Strategic Message Design Is Needed to Change Behavior.

Noelle K LoConte, Margaret E Gatti-Mays, Kelly A Hirko

|Jun 13, 2025
Effect of Intolerance of Uncertainty on Perceived Cognitive Function Among Breast Cancer Patients Before Chemotherapy.

Yesol Yang, Alai Tan, Sagar D Sardesai

|Nov 15, 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer.

Lauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman

|Jun 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.

Kai C C Johnson, Ai Ni, Dionisia Quiroga

|Jun 09, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.

Mary L Disis, Sarah F Adams, Jyoti Bajpai

Pageof 3

Frequent Collaborators

4 joint publications

Jeffrey Schlom

4 joint publications

James L Gulley

3 joint publications

Jason Redman

3 joint publications

Caroline Jochems